WD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WD is not a good buy right now for an impatient buyer. The stock just sold off (-2.68% close) and is trading below the pivot (63.994) and only slightly above near-term support (S1 62.03), with momentum indicators not yet turning decisively higher. Despite generally bullish Wall Street ratings and meaningful upside to recent price targets ($75–$80 vs $62.89), the lack of near-term catalysts/news and no proprietary buy signals makes the risk/reward unattractive for an immediate entry. Best action now: HOLD (not a buy today).
Trend/Momentum: Price closed at 62.89, below the pivot level (63.994), indicating near-term bearish to neutral control. The next key level is S1 at 62.03 (nearby), then S2 at 60.817; resistance sits at 65.957 (R1) and 67.17 (R2). MACD histogram is slightly positive (0.0555) but contracting, implying bullish momentum is fading rather than strengthening. RSI(6) ~40 is weak/soft (not oversold, but closer to downside pressure than upside strength). Moving averages are converging, consistent with a choppy/indecisive regime rather than a clean uptrend. Near-term read: not a strong technical buy setup until it reclaims the pivot and holds above ~66 (R1) or shows a clearer bounce off S1 with improving momentum.
Intellectia Proprietary Trading Signals
Fundamentals improving: 2025/Q3 showed strong YoY growth (revenue +16.95%, net income +15.78%, EPS +15.29%).
Analyst stance is broadly positive: multiple Outperform/Buy ratings with price targets well above the current price (recent targets $75–$80).
Pattern-based forward look provided indicates a positive bias over the next week (+3.08% expected by the referenced historical analog set), though probabilities are not overwhelming.
Weak near-term tape: sharp down day and the stock is below the pivot, with MACD momentum contracting (not an ideal immediate entry).
Analyst price targets have been repeatedly trimmed (e.g., Keefe Bruyette: 97→92→82→80 over recent months), signaling tempered expectations even while maintaining Outperform.
No news/catalysts in the last week to drive a near-term re-rating.
Earnings upcoming (QDEC 2025 on 2026-02-10 pre-market) could create a wait-and-see posture in the near term, and options imply elevated expected movement.
Latest reported quarter: 2025/Q3. Revenue rose to $306.031M (+16.95% YoY), net income increased to $32.623M (+15.78% YoY), and EPS increased to $0.98 (+15.29% YoY). Gross margin dipped slightly to 94.44% (-0.70% YoY), a modest profitability headwind but not enough to offset the overall growth profile. Overall: solid growth trend in the latest quarter, supportive for the longer-term bull case.
Recent analyst trend: Ratings remain bullish (Outperform/Buy), but price targets have been gradually reduced. Keefe Bruyette kept Outperform while cutting PT multiple times ($97→$92→$82→$80). Jefferies initiated with a Buy and $75 PT, citing a multi-leg growth story and expectations that GSE repurchase requirement concerns fade over the next year. Wall Street pros: improving CRE recovery narrative into 2026 and strong business momentum reflected in Q3 growth; targets imply sizable upside from $62.89. Wall Street cons: repeated PT cuts indicate reduced near-term confidence/valuation compression concerns; current trading action does not confirm the bullish thesis yet. Influential/Political trading: No recent congress trading data available; hedge funds and insiders are neutral with no significant recent trends.
